Nath Bio-Genes (India) Limited - Company Profile

It is a agriculture public limited company based in Aurangabad, Maharashtra, India, established in 1993.

1993 Aurangabad, Maharashtra, India Active

Last Updated: December 22, 2025

About Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited, a active public limited company, was established on 14 July 1993 in Aurangabad, Maharashtra, India. Engaging in seed production & distribution within the agriculture, forestry, fishing sector, it holds CIN: L01110MH1993PLC072842. Registered under ROC Roc Mumbai. it is listed on BSE: 537291 and NSE: NATHBIOGEN. It has an authorized capital of ₹21.00 Cr and a paid-up capital of ₹19.00 Cr.

It upholds a compliant status. In 2023, it reported revenue of ₹301.85 Cr and a net worth of ₹573.35 Cr. Employing 417 professional, Its leadership includes Vadla Nagabhushanam (Director), Akash Nandkishor Kagliwal (Director), Jeevanlata Nandkishor Kagliwal (Director). Past directors included Sweta Akash Kagliwal, Pramod Kumar Gupta, Vadla Nagabhushanam. It holds ₹114.10 Cr open charges and ₹183.20 Cr settled loans. Its latest AGM occurred on 22 August 2025, with the balance sheet filed on 31 March 2025. It is based at Nath House Nath Road, Aurangabad, Maharashtra, 431005.

Company Details

CIN/LLPIN
L01110MH1993PLC072842
Registration Number
072842
Incorporation Date
14 July 1993
Authorized Capital
₹21.00 Cr
Paid-Up Capital
₹19.00 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 537291, NSE: NATHBIOGEN)
Company Status
Active

Key Metrics

Authorised Capital ₹ 21.00 Cr as on 22-12-2025
Paid Up Capital ₹ 19.00 Cr as on 22-12-2025
Company Age 32 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 114.10 Cr as on 22-12-2025
Satisfied Charges ₹ 183.20 Cr as on 22-12-2025
Revenue Growth **** 7.72% (FY 2023)
Profit Growth **** 152.22% (FY 2023)
Ebitda **** 31.30% (FY 2023)
Net Worth 5.79% (FY 2023)
Total Assets **** 6.88% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Nath Bio-Genes (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Nath Bio-Genes (India) Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vadla Nagabhushanam	Director	07 Nov 2020	Current
Akash Nandkishor Kagliwal	Director	22 Apr 2023	Current
Jeevanlata Nandkishor Kagliwal	Director	30 May 2019	Current
Madhukar Dhondiraj Deshpande	Director	10 Feb 2021	Current
Hitesh Rajnikant Purohit	Director	30 Mar 2022	Current
Satish Laxminarayan Kagliwal	Managing Director	29 Mar 2000	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	08 Aug 2015	Past
Pramod Abcsdd	Nominee Director	03 Oct 2016	Past
Pramod Abcsdd	Additional Director	27 Aug 2021	Past
Pramod Abcsdd	Director	10 Oct 2012	Past
Pramod Abcsdd	Director	10 Oct 2012	Past
Pramod Abcsdd	Additional Director	10 Aug 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nath Bio-Genes (India).

Nath Bio-Genes (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.72% increase. The company also saw a substantial improvement in profitability, with a 152.22% increase in profit. The company's net worth moved up by a moderate rise of 5.79%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.72%

*******

Revenue from Operations

*******

8.24%

*******

Total Assets

*******

6.88%

*******

Profit or Loss

*******

152.22%

*******

Net Worth

*******

5.79%

*******

EBITDA

*******

31.30%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nath Bio-Genes (India)?

In 2023, Nath Bio-Genes (India) had a promoter holding of 45.59% and a public holding of 54.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,140,950,000.00

Satisfied Charges

₹1,832,000,000.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 105.40 Cr
Others : 5.80 Cr
Hdfc Bank Limited : 2.90 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Jul 2025	Others	₹5.00 Cr	Open
13 Jun 2025	Others	₹8.00 M	Open
21 Jun 2024	Axis Bank Limited	₹1.03 M	Open
03 Apr 2024	Hdfc Bank Limited	₹5.78 M	Open
06 Mar 2024	Hdfc Bank Limited	₹3.15 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Nath Bio-Genes (India)?

Nath Bio-Genes (India) has a workforce of 417 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nath Bio-Genes (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nath Bio-Genes (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nath Bio-Genes (India)

Recent Activity within the Organization

Annual General Meeting

Nath Bio-Genes (India) Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records. was recorded as a recent event.
22 Aug 2025
Charges

The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101141509 was registered on 30 Jul 2025. was completed.
30 Jul 2025
Director Appointment

Progress on Payal Dilipkumar Jain was appointed as a Director was appointed as a Director on 11 Jul 2025 & has been associated with this company since 7 months 5 days . was documented.
11 Jul 2025
Charges

A charge with Others amounted to Rs. 0.80 Cr with Charge ID 101139826 was registered on 13 Jun 2025. was recorded as a recent event.
13 Jun 2025
Balance Sheet

Nath Bio-Genes (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

Amol Arunrao Gupta was appointed as a Cfo was appointed as a Cfo on 03 Jan 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.
03 Jan 2025

Explore recent activity and updates - View Recent Activity